BioFlo DuraMax with Endexo® Technology Chronic Hemodialysis VascPak, Single Valve - Catheter, haemodialysis, implantable - TGA Drug Approval Details
Approvals/TGA/BioFlo DuraMax with Endexo® Technology Chronic Hemodialysis VascPak, Single Valve - Catheter, haemodialysis, implantable
Approved
STANDARD
BioFlo DuraMax with Endexo® Technology Chronic Hemodialysis VascPak, Single Valve - Catheter, haemodialysis, implantable
Merit Medical Australia Pty Ltd🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
96eb18862c71fe01
Company
Merit Medical Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
96eb18862c71fe01
Product Name
BioFlo DuraMax with Endexo® Technology Chronic Hemodialysis VascPak, Single Valve - Catheter, haemodialysis, implantable
Artg Id
514868
Artg Name
Merit Medical Australia Pty Ltd - BioFlo DuraMax with Endexo® Technology Chronic Hemodialysis VascPak, Single Valve - Catheter, haemodialysis, implantable
